View Andres's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
About Andres Salas
Andres Salas is Chief Executive Officer at Bioarray Genetic Diagnosis in spain. Previously worked at resimol, s.l. as Chief Executive Officer. Bioarray Genetic Diagnosis is a Medical and Diagnostic Laboratories company in Parque Científico y Empresarial de la UMH
Edificio Quorum III
Elche, Alicante 03330, ES with 37 employees
Andres Salas Social
Andres Salas Work
Andres Salas is the Chief Executive Officer @Bioarray Genetic Diagnosis, with experience in Chief Executive Officer @resimol, s.l.
Bioarray is a genetic testing provider, serving clinical partners in Europe, Latin America, MENA and Asia. Mainly using array CGH and NGS for:
- Medical Genetics: WES, WGS
- Reproductive Genetics: expanded carrier screening, preimplantation genetic testing (PGT), endometrial receptivity and prenatal diagnosis
- Oncology: somatic and germline tests, liquid biopsy
Bioarray is also a leading provider of research services, as gene expression studies based on array or RNA-seq.
Bioarray’s sister company Journey Genomics launched PGD-Seq™, a kit for library preparation and data analysis, for easy PGT-M implementation for NGS labs.
Andres Salas completed
at universitat d'alacant (Present)
universitat d'alacant
marketing
Present
More About Andres Salas
Skills
estrategia empresarial, mercadotecnia, market analysis, estrategia de mercadotecnia, start ups, product development, business strategy, marketing, biotechnology, plan de negocio, lifesciences, marketing strategy, market research, international sales, international business, commercialization, entrepreneurship, competitive analysis, marketing management, lanzamiento de productos, business planning, online advertising, negotiation, strategic planning, new business development, international marketing, product launch, product marketing
Andres Salas Email & Phone number
These email and Phone numbers are the most updated and verified contact information for Andres Salas found in 2025.